Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Recs

0
Player Avatar jsgant13 (97.73) Submitted: 11/15/2010 12:39:38 PM : Outperform Start Price: $25.17 VRX Score: +83.33

VALUEACT HOLDING

Featured Broker Partners


Advertisement